SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

The SolyCat is a symbol of energy and mystery. Shining like the sun and agile as a feline.  Solycat is here to take over Solana! Inspired by Shiba Inu’s legendary rise on Ethereum, Solycat is the ultimate meme coin designed for Solana’s fast and scalable blockchain.  Our mission is simple: become the top cat of Solana. With bold branding, a vibrant community, and unstoppable momentum, Solycat is ready to dominate. This isn’t just another token—it’s a movement powered by fun, creativity, and the spirit of decentralization.  Join the pride and let’s make history, one paw at a time!

Solycat

Solycat ($SOLYCAT) is trending as community members discuss its recent listing and availability on Phantom Wallet. The Solana-based token is being touted for its potential gains, with many highlighting its strong momentum and comparing it to other meme coins. Some users note its relative stability amidst broader market volatility.

Memecoin on Cronos launched by the Cro Crow community

crow with knife

The meme coin $CAW, also known as crow with knife, is trending as the community buzzes about its multichain presence across Solana, BSC, CRO, and ETH, plus its deflationary mechanism. Community members highlight its organic growth and partnerships, while also mentioning staking opportunities may be coming.

ProShares Trust - ProShares Short Dow30 -1x Shares

ProShares Short Dow30

ProShares Short Dow30 ($DOG) is trending as the community rallies behind it as the top memecoin on Bitcoin, emphasizing its fair launch and strong community-driven nature. Discussions highlight its potential to outperform other memecoins and its unique position within the Bitcoin ecosystem. Community members are actively promoting its listing on major exchanges and emphasizing its potential for significant growth.

Kura Oncology, Inc. operates as a clinical-stage biopharmaceutical company, which engages in the research and development of medicines for the treatment of cancer. Its pipeline includes Tipifarnib, which is a Farnesyl transferase inhibitor for HRAS Mutant Solid Tumors, Chronic Myelomonocytic Leukemia, KO-947, which is an ERK inhibitor for MAPK Pathway Tumors, and KO-539, which is a Menin MLL inhibitor for acute leukemias. The company was founded by Troy E. Wilson, Yi Liu, Pingda Ren and Antonio Gualberto on August 22, 2014 and is headquartered in San Diego, CA.

Kura Oncology Inc

Kura Oncology is trending due to a collaboration with Kyowa Kirin to develop and commercialize ziftomenib, with the community debating the deal's long-term impact despite a recent milestone payment. Discussions also involve comparing Kura's safety profile to competitors like $SNDX and anticipating potential FDA approval, with some speculating on a possible buyout. Bullish sentiment stems from ziftomenib's potential in treating acute myeloid leukemia and the company's strong cash position.

BioCryst Pharmaceuticals, Inc. is a biotechnology company. It engages in the provision of structure-guided drug design with the goal of developing oral small-molecule and protein therapeutics to target difficult-to-treat rare diseases. The company was founded by William M. Spencer III, Charles E. Bugg, and John A. Montgomery in 1986 and is headquartered in Durham, NC.

Biocryst Pharmaceuticals Inc.

BCRX is trending amidst discussions on tariffs, CPI, and their potential impact, with community members debating whether previous losses have been recovered adequately. Chatter includes short interest, potential revenue beats, and forward-looking market valuation. The stock is also reacting to broader market forces like gold price fluctuations and sector-specific news from competitors.

Grayscale Bitcoin Mini Trust ETF - Common units of fractional undivided beneficial interest

Grayscale Bitcoin Mini Trust ETF

Grayscale Bitcoin Mini Trust ETF ($BTC) is buzzing as Bitcoin flirts with all-time highs, driven by potential regulatory shifts and growing institutional interest. Community members are closely watching key resistance levels and debating whether Bitcoin's surge will continue or if a correction is on the horizon. The focus remains on Bitcoin's potential as both a safe haven and a growth asset amid economic uncertainty.

Cronos is an institutional-grade, high-performance, EVM-compatible Layer-1 blockchain built on the Cosmos SDK and integrated with the Inter-Blockchain Communication (IBC) protocol, designed as the backbone for open, compliant, and AI-accessible tokenized markets. It supports up to 60,000 transactions per second (TPS), 500ms block times, instant finality, and sub-$0.01 fees via Proof of Authority consensus.

Crypto.com Coin

Crypto.com Coin is trending as the community debates its potential to break key resistance levels amid general market volatility, with some expressing frustration over its price action relative to Bitcoin and Binance Coin. There's also buzz around the coin's association with memecoins and upcoming catalysts like potential ETF approval and new partnerships for the Cronos chain. Community members are weighing the potential impact of these developments on CRO's price.

Zebec's integrated products - real time payroll apps, on-chain payments infrastructure and networked DePIN - serve companies of all sizes, merchants and individuals and help transcend the boundaries of traditional banking and diminish the role of financial intermediaries.

Zebec Network

Zebec Network is trending amid anticipation for its Super App release and upcoming listings on major exchanges like Coinbase and Binance. The community is bullish, drawing comparisons to XRP and highlighting potential NBA and NHL sponsorships. Discussions also involve the project's utility in payroll and staking rewards through Uphold.

Biogen, Inc. is a biopharmaceutical company, which engages in discovering, developing, and delivering therapies for neurological and neurodegenerative diseases. Its products include TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI and FAMPYRA for the treatment of MS, SPINRAZA for the treatment of SMA, ADUHELM for the treatment of Alzheimer's disease, and FUMADERM for the treatment of severe plaque psoriasis. The company was founded by Charles Weissmann, Heinz Schaller, Kenneth Murray, Walter Gilbert, and Phillip Allen Sharp in 1978 and is headquartered in Cambridge, MA.

Biogen Inc

Biogen ($BIIB) is trending due to its licensing deal with Vanqua Bio for an oral C5aR1 antagonist, signaling renewed interest in the C5aR pathway; the community is actively discussing the implications of this deal for InflaRx ($IFRX) and other companies in the sector. Discussions involve speculation on potential revenue and the competitive landscape. Also of interest are Biogen's earnings, drug pipeline, and potential for growth.

Teledyne Technologies, Inc. engages in the provision of electronic and communication products for wireless and satellite systems. It operates through the following business segments: Instrumentation, Digital Imaging, Aerospace and Defense Electronics, and Engineered Systems. The Instrumentation segment provides monitoring and control instruments for marine, environmental, industrial, and other applications, and electronic test and measurement equipment. The Digital Imaging segment includes high-performance sensors, cameras, and systems within the visible, infrared, ultraviolet, and X-ray spectra. The Aerospace and Defense Electronics segment offers electronic components and subsystems, data acquisition and communications components and equipment, harsh environment interconnects, and general aviation batteries. The Engineered Systems segment consists of systems engineering, integration and advanced technology development, and complex manufacturing solutions. The company was founded in 1960 and is headquartered in Thousand Oaks, CA.

Teledyne Technologies Inc

Teledyne Technologies ($TDY) is trending due to recent analyst activity, including price target adjustments, and discussions around its growth strategies and performance in the defense and aerospace sectors. The community is focused on the company's potential in areas like drones and AI, as well as its recent earnings and contract wins, with some expressing disappointment in the stock's price movement despite positive news.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Gorilla Technology Group Inc. (GRRR) stock was in the spotlight in Tuesday’s premarket session as retail investors expressed confidence about the company’s recent contract wins and its operations in AI infrastructure and intelligence.&nbsp;The stock traded over 5% higher on Tuesday morning and was among the top five trending equity tickers on Stocktwits. Gorilla stock also experienced a 372% surge in user message count over the last 24 hours.&nbsp;A bullish Stocktwits user stated that the stock should be $40 or more at this time. “Many other lesser stocks are trading much higher than that. Unbelievable! Way way undervalued. Let it run!”<stembedurl>https://stocktwits.com/ChiefStockTraderJr/message/631201379</stembedurl>Another user highlighted the company’s recent $1.4 billion data center deal.&nbsp;<stembedurl>https://stocktwits.com/mikesterz7/message/631273798</stembedurl>The company&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/gorilla-technology-stock-soared-nearly-10-percent-today-here-is-an-update/chDGrgsRd6j">disclosed</a> on September 17 that it had finalized a binding three-year deal worth $1.4 billion with infrastructure firm Freyr Singapore. The initial phase of the project, known as “Phase One,” carries a value of $300 million and is scheduled to launch in the fourth quarter of 2025. Under the provisions of the agreement, Gorilla will be the chief operator and AI infrastructure provider, responsible for implementing advanced computing systems across Indonesia, Malaysia, and Thailand.&nbsp;Additionally, the company landed another major government deal in the Asia-Pacific region on September 8. The one-year contract, worth tens of millions of dollars, will support AI-driven smart policing through GPU-as-a-Service.In a recent fireside chat, Gorilla’s Chairman and CEO, Jayesh Chandan, said the company is a full-stack builder and operator of sovereign AI infrastructure. “Today, more than 80% of our revenue is actually government and public agencies,” said Chandan.&nbsp;Gorilla Technology stock has gained over 14% in 2025 and over 406% in the last 12 months.&nbsp;Also See:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/paul-tudor-jones-sees-market-blow-off-phase-ahead/ch6PPr0R3WL">Paul Tudor Jones Sees Market ‘Blow-Off’ Phase Ahead, But Expects Further Rally On Pure FOMO: ‘All Ingredients Are In Place’</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

In this photo illustration, the Gorilla Technology logo is seen displayed on a smartphone screen. 

GRRR Shares Rally Over 4% Pre-Market, Retail Says Stock Should Be Trading Over $40: ‘Unbelievable! Way, Way Undervalued’

Gorilla Technology stock experienced a 372% surge in user message count on Stocktwits over the last 24 hours.

Equity

Gorilla Technology stock experienced a 372% surge in user message count on Stocktwits over the last 24 hours.


Baidu's AI Buzz vs. Revenue Reality: Time for Investors to Cash Out?

BIDU's AI hype can't mask the reality of -45% operating income, negative cash flow, and declining core business, making this stock a clear sell.

iQIYI sees surge in viewership during Chinese New Year: users favor classic IPs, long and short content, and strong interaction

iQIYI sees surge in viewership during Chinese New Year: users favor classic IPs, long and short content, and strong interaction iQIYI sees surge in viewership during Chinese New Year: users favor...

iQIYI upgrades Diamond VIP benefits, enhancing unmatched membership experience

iQIYI upgrades Diamond VIP benefits, enhancing unmatched membership experience iQIYI upgrades Diamond VIP benefits, enhancing unmatched membership experience PR Newswire BEIJING, Jan. 24, 2025...

iQIYI's hit drama 'Mysterious Lotus Casebook' showcases diversified development model, another case proving the Value of IP

iQIYI's hit drama 'Mysterious Lotus Casebook' showcases diversified development model, another case proving the Value of IP iQIYI's hit drama 'Mysterious Lotus Casebook' showcases diversified...

iQIYI leads genre-specific storytelling with the return of its trend-setting 'Light On Theater,' featuring seven new suspense dramas

iQIYI leads genre-specific storytelling with the return of its trend-setting 'Light On Theater,' featuring seven new suspense dramas iQIYI leads genre-specific storytelling with the return of its...

iQIYI Celebrates Content Excellence and Social Impact at Scream Night 2024

iQIYI Celebrates Content Excellence and Social Impact at Scream Night 2024 iQIYI Celebrates Content Excellence and Social Impact at Scream Night 2024 PR Newswire BEIJING, Dec. 11, 2024 BEIJING, Dec...

iQIYI Introduces 'Extra Large Font' Function to Enhance Accessibility for Senior Users

iQIYI Introduces 'Extra Large Font' Function to Enhance Accessibility for Senior Users iQIYI Introduces 'Extra Large Font' Function to Enhance Accessibility for Senior Users PR Newswire BEIJING, Dec...

iQIYI Introduces Standard VIP Family and Friends Membership to Enhance Subscription Flexibility and Premium Content Access

iQIYI Introduces Standard VIP Family and Friends Membership to Enhance Subscription Flexibility and Premium Content Access iQIYI Introduces Standard VIP Family and Friends Membership to Enhance...

iQIYI's 'Love On Theater' Premieres 'Fangs of Fortune,' Setting Benchmark for C-Drama Virtual Production

iQIYI's 'Love On Theater' Premieres 'Fangs of Fortune,' Setting Benchmark for C-Drama Virtual Production iQIYI's 'Love On Theater' Premieres 'Fangs of Fortune,' Setting Benchmark for C-Drama Virtual...

iQIYI, Inc. provides online entertainment services. It attracts a massive user base with tremendous user engagement, and has developed a diversified monetization model including membership services, online advertising services, content distribution, online games, live broadcasting, IP licensing, talent agency and online literature. The firm distinguishes itself in the online entertainment industry by its technology platform powered by advanced AI, big data analytics and other core proprietary technologies. The company was founded by Yu Gong on November 27, 2009 and is headquartered in Haidan District, China.

iQIYI Inc - ADR

Cut 25 bps

Cut 50+ bps

No change

What will the Fed decide at its October meeting? Polymarket gives a 92% chance of a 25 bps cut. 
 
*Powered by Polymarket

Current Price	N/A
Prev Close	N/A
Open	N/A
Dividend Yield	0.00%
50-Day Moving Average	$2.46
Beta	1.29
Avg. Volume	14.89M
PE Ratio	170.31

52-Week High	$2.85
52-Week Low	$1.50
Market Capitalization	$2.12B
EPS (Annual)	$0.1104
Price to Book	1.11
Revenue Per Employee	$869,004.01
Enterprise Value/EBITDA	N/A

IQ
iQIYI Inc - ADR

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest IQ News

IQiQIYI Inc - ADR